- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Hypha Labs, Inc.: Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls Prototypes | 168 | ACCESSWIRE | Advancements Enhance Efficacy in Hypha's Revolutionary Home and Commercial Production UnitsLAS VEGAS, NV / ACCESSWIRE / November 18, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom... ► Artikel lesen | |
| 17.10. | Hypha Labs Inc. and Emerging Markets Consulting LLC: Emerging Markets Report: A Mushroom Monster in the Making | 1 | GlobeNewswire (USA) | ||
| 15.10. | Hypha Labs, Inc.: Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown | 195 | ACCESSWIRE | Board Will Add to Company's Intellectual Capital and Diversity of ExperienceLAS VEGAS, NV / ACCESSWIRE / October 15, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and... ► Artikel lesen | |
| 07.10. | Hypha Labs, Inc.: Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production | 208 | ACCESSWIRE | Company Intends to Bring First Functional Mushroom Producer to RetailLAS VEGAS, NV / ACCESSWIRE / October 7, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator... ► Artikel lesen | |
| 30.09. | Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production | 195 | ACCESSWIRE | First Generation 'MicroPearls Pro'and "MicroPearls ProX" Will Support Largest Mushroom Ingredient CategoriesLAS VEGAS, NV / ACCESSWIRE / September 30, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer... ► Artikel lesen | |
| 26.09. | Hypha Labs, Inc.: Functional Mushroom Company Hypha Labs Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services | 205 | ACCESSWIRE | LAS VEGAS, NV / ACCESSWIRE / September 26, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company has retained Emerging Markets Consulting... ► Artikel lesen | |
| 23.09. | Hypha Labs, Inc. Releases Investor Presentation | 202 | ACCESSWIRE | Dynamic Deck Outlines Company's Plan to Empower Home and Commercial Production of Functional Mushroom Ingredients LAS VEGAS, NV / ACCESSWIRE / September 23, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer... ► Artikel lesen | |
| 16.09. | Hypha Labs, Inc. Uplists to the OTCQB | 289 | ACCESSWIRE | OTCQB Listing Brings Transparency, Prestige and Beneficial Exposure LAS VEGAS, NV / ACCESSWIRE / September 16, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, is pleased... ► Artikel lesen | |
| HYPHA LABS Aktie jetzt für 0€ handeln | |||||
| 20.08. | Hypha Labs, Inc.: Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press | 245 | ACCESSWIRE | LAS VEGAS, NV / ACCESSWIRE / August 20, 2024 / Hypha Labs, Inc. (OTC PINK:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company's proprietary bioreactor which allows... ► Artikel lesen | |
| 14.08. | Hypha Labs, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.08. | Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. | 486 | ACCESSWIRE | LAS VEGAS, NV / ACCESSWIRE / August 13, 2024 / Hypha Labs, Inc. formerly (OTC PINK:DIGP), has been approved to commence trading as Hypha Labs, Inc. (OTC PINK:FUNI) on August 13, 2024. Hypha Labs has... ► Artikel lesen | |
| 31.07. | Hypha Labs, Inc.: Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press | 312 | ACCESSWIRE | LAS VEGAS, NV / ACCESSWIRE / July 31, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased to announce that the Company's proprietary bioreactor which allows... ► Artikel lesen | |
| 20.07. | Hypha Labs, Inc.: Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications | 1.037 | ACCESSWIRE | Veteran Agency Brings Twenty-Five Years of Experience and Relationships to Emerging Functional Mushroom Science CompanyLAS VEGAS, NV / ACCESSWIRE / July 19, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP),... ► Artikel lesen | |
| 20.07. | Hypha Labs, Inc.: Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence Driven In-Home Mycelium Production | 1.075 | ACCESSWIRE | Company Intends to Bring First Functional Mushroom Producer to RetailLAS VEGAS, NV / ACCESSWIRE / July 19, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased... ► Artikel lesen | |
| 20.05. | Hypha Labs, Inc.: Hypha Labs Announces New Patent Filing | 444 | ACCESSWIRE | New Patent Portfolio Unveiled Revolutionizing Psilocybin ProcessingLAS VEGAS, NV / ACCESSWIRE / May 20, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP) Today marks a significant milestone in the realm of mycological... ► Artikel lesen | |
| 29.04. | Hypha Labs, Inc.: Hypha Labs Names Craig Ellins Chief Science Officer | 456 | ACCESSWIRE | LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Hypha Labs, Inc. (OTC Pink:DIGP) has announced that it has made Craig Ellins its Chief Science Officer. Hypha Labs, Inc. changed its name from Digipath... ► Artikel lesen | |
| 22.04. | DigiPath, Inc.: Digipath Enters Psilocybin Industry and Changes Name | 309 | ACCESSWIRE | LAS VEGAS, NV / ACCESSWIRE / April 22, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP) has announced that it has changed its name from Digipath, Inc. after the sale of its cannabis lab assets. In a change of... ► Artikel lesen | |
| 18.04. | Hypha Labs, Inc. to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 | 219 | ACCESSWIRE | LAS VEGAS, NV / ACCESSWIRE / March 18, 2024 / Hypha Labs, Inc. (OTC Pink:DIGP), short company description, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 40,220 | +3,55 % | DAX fehlen die Impulse. Qiagen deutet Gegenbewegung an | ||
| EVOTEC | 10,070 | +1,67 % | Märkte am Morgen: Bitcoin, Talanx, Evotec, ASML, Infineon, Domino's Pizza, Palantir | Der DAX sich gestern von seiner starken Seite präsentiert und kräftig zugelegt. Am Ende ging der Leitindex 1,37 Prozent höher bei 19.263 Punkten aus dem Handel. Heute muss er mit unterschiedlichen Vorgabe... ► Artikel lesen | |
| BEAM THERAPEUTICS | 23,580 | -3,72 % | Beam Therapeutics Inc. (NASDAQ:BEAM) Sees Large Increase in Short Interest | ||
| IMMUNOVANT | 26,540 | 0,00 % | Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024? | ||
| BIONTECH | 103,40 | 0,00 % | Die meistgehandelten Produkte: BioNTech verstärkt sich mit Übernahme! | ||
| KEROS THERAPEUTICS | 53,84 | -0,55 % | Keros Therapeutics, Inc.: Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results | LEXINGTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros" or the "Company") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing... ► Artikel lesen | |
| JANUX THERAPEUTICS | 46,500 | -5,02 % | Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights | SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 5,755 | 0,00 % | Recursion Pharmaceuticals, Inc.: Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery | Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will... ► Artikel lesen | |
| GALAPAGOS NV | 24,000 | -0,08 % | GALAPAGOS NV - S-8, Securities to be offered to employees in employee benefit plans | ||
| AVIDITY BIOSCIENCES | 42,530 | -2,57 % | Avidity Biosciences, Inc.: Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights | Enrollment in global Phase 3 HARBOR study for del-desiran in DM1 is on track
Avidity initiated biomarker cohort for del-brax FORTITUDE study for FSHD; pursuing a... ► Artikel lesen | |
| LONGBOARD PHARMACEUTICALS | 59,78 | +0,03 % | Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates | LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological... ► Artikel lesen | |
| BB BIOTECH | 38,650 | 0,00 % | PTA-News: Small- & MicroCap Investment: BB Biotech, Bright Minds, NurExone: Biotech-Konzerne sichern sich erfolgreich Privatplatzierungen | DJ PTA-News: Small- & MicroCap Investment: BB Biotech, Bright Minds, NurExone: Biotech-Konzerne sichern sich erfolgreich Privatplatzierungen
Unternehmensmitteilung für den Kapitalmarkt
Frankfurt... ► Artikel lesen | |
| NUVALENT | 92,65 | 0,00 % | Nuvalent-CEO Porter verkauft Aktien im Wert von 2,37 Millionen US-Dollar | ||
| SPRINGWORKS THERAPEUTICS | 36,300 | 0,00 % | SpringWorks started at outperform by Evercore ahead of FDA decision | ||
| ARCTURUS THERAPEUTICS | 17,070 | +5,57 % | Arcturus Therapeutics Holdings Inc.: Arcturus Therapeutics to Present at Jefferies London Healthcare Conference | Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities... ► Artikel lesen |
HYPHA LABS INC gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HYPHA LABS INC finden Sie auf Wallstreet Online.
